Evaluating the effects of Anthelios sunscreen on skin aging
Evaluation of the Efficacy of the UVMune 400 Fluid Sunscreen on the Face Versus Usual Photoprotection Routine on Visible and Measurable Signs of Aging
This study is testing whether using Anthelios sunscreen can help prevent signs of skin aging better than regular skincare routines.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 260 (estimated) |
| Ages | 30 Years to 60 Years |
| Sex | All |
| Sponsor | Cosmetique Active International Industry-sponsored |
| Locations | 1 site (Rio de Janeiro) |
| Trial ID | NCT06697288 on ClinicalTrials.gov |
What this trial studies
This experimental study aims to assess the preventative effects of Anthelios UVMUNE 400 Fluid SPF 50+ sunscreen on clinical signs of skin aging compared to usual skincare routines. Participants will be randomly assigned to either the sunscreen group or a control group. The study will follow strict protocols and regulatory guidelines to ensure accurate and reliable results. Data will be analyzed using statistical methods to evaluate the efficacy of the sunscreen over time.
Who should consider this trial
Good fit: Ideal candidates are individuals showing signs of photo aging with a global score of at least 14, regardless of skin type.
Not a fit: Patients with significant dermatological conditions or known allergies to cosmetic products may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide evidence for the effectiveness of high SPF sunscreen in preventing signs of skin aging.
How similar studies have performed: Previous studies have shown positive outcomes with similar sunscreen interventions, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects with signs of photo aging (Global score of at least 14) * All skin types Exclusion Criteria: * Any history of significant dermatological/ophthalmological diseases or conditions or medical conditions known to alter skin appearance or physiologic response (e.g. diabetes,) which could, in the opinion of the Investigator, preclude topical application of the investigational products and/or interfere with the evaluation of the test site * Pregnant or breastfeeding women * Subject with known allergy to cosmetic products or to any ingredient of the sunscreen product
Where this trial is running
Rio de Janeiro
- Cidp — Rio de Janeiro, Brazil (Recruiting)
Study contacts
- Principal investigator: Renato Moura — Centre International de Développement Pharmaceutique
- Study coordinator: Renato Moura
- Email: renato.moura.b@gmail.com
- Phone: (55) 21 2221 6180
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.